Suppr超能文献

新生儿抗生素给药:药代动力学数据综述

Dosing antibiotics in neonates: review of the pharmacokinetic data.

作者信息

Rivera-Chaparro Nazario D, Cohen-Wolkowiez Michael, Greenberg Rachel G

机构信息

Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27705, USA.

Department of Pediatrics, Duke University, Durham, NC 27710, USA.

出版信息

Future Microbiol. 2017 Sep;12(11):1001-1016. doi: 10.2217/fmb-2017-0058. Epub 2017 Jul 31.

Abstract

Antibiotics are often used in neonates despite the absence of relevant dosing information in drug labels. For neonatal dosing, clinicians must extrapolate data from studies for adults and older children, who have strikingly different physiologies. As a result, dosing extrapolation can lead to increased toxicity or efficacy failures in neonates. Driven by these differences and recent legislation mandating the study of drugs in children and neonates, an increasing number of pharmacokinetic studies of antibiotics are being performed in neonates. These studies have led to new dosing recommendations with particular consideration for neonate body size and maturation. Herein, we highlight the available pharmacokinetic data for commonly used systemic antibiotics in neonates.

摘要

尽管药品标签中缺乏相关给药信息,但抗生素仍经常用于新生儿。对于新生儿给药,临床医生必须从针对成年人和大龄儿童的研究中推断数据,而这些人群的生理机能显著不同。因此,剂量推断可能会导致新生儿中毒风险增加或疗效不佳。受这些差异以及近期强制要求开展儿童和新生儿药物研究的法规推动,越来越多针对新生儿的抗生素药代动力学研究正在进行。这些研究已产生了新的给药建议,特别考虑了新生儿的体型和发育情况。在此,我们重点介绍新生儿常用全身性抗生素的现有药代动力学数据。

相似文献

1
Dosing antibiotics in neonates: review of the pharmacokinetic data.
Future Microbiol. 2017 Sep;12(11):1001-1016. doi: 10.2217/fmb-2017-0058. Epub 2017 Jul 31.
2
New antibiotic dosing in infants.
Clin Perinatol. 2015 Mar;42(1):167-76, ix-x. doi: 10.1016/j.clp.2014.10.009. Epub 2014 Nov 27.
5
New dosing strategies for antibacterial agents in the neonate.
Semin Fetal Neonatal Med. 2005 Apr;10(2):185-94. doi: 10.1016/j.siny.2004.10.004. Epub 2004 Dec 1.
6
Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.
Antimicrob Agents Chemother. 2010 Nov;54(11):4950. doi: 10.1128/AAC.00754-10. Epub 2010 Sep 7.
10
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants.
Eur J Clin Pharmacol. 2013 Jun;69(6):1223-33. doi: 10.1007/s00228-012-1413-4. Epub 2013 Jan 26.

引用本文的文献

1
Externally validated population pharmacokinetics of amikacin and evaluation of dosage regimen based on achieved serum concentrations in neonates.
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0081825. doi: 10.1128/aac.00818-25. Epub 2025 Jul 17.
3
Predictors of gentamicin therapy failure in neonates with sepsis.
Pharmacol Res Perspect. 2024 Aug;12(4):e1250. doi: 10.1002/prp2.1250.
5
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice.
Antibiotics (Basel). 2023 Mar 17;12(3):602. doi: 10.3390/antibiotics12030602.
6
Variation in ampicillin dosing for lower respiratory tract infections and neonatal bacterial infections in US children's hospitals.
Antimicrob Steward Healthc Epidemiol. 2022 May 23;2(1):e85. doi: 10.1017/ash.2022.221. eCollection 2022.
7
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units.
Int J Clin Pharm. 2022 Apr;44(2):564-569. doi: 10.1007/s11096-021-01345-9. Epub 2021 Nov 2.
8
Neonatal multidrug-resistant gram-negative infection: epidemiology, mechanisms of resistance, and management.
Pediatr Res. 2022 Jan;91(2):380-391. doi: 10.1038/s41390-021-01745-7. Epub 2021 Oct 1.
9
Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research.
Pediatr Res. 2022 Jan;91(2):368-379. doi: 10.1038/s41390-021-01721-1. Epub 2021 Sep 8.

本文引用的文献

4
Transparency in drug regulation: public assessment reports in Europe and Australia.
Drug Discov Today. 2016 Nov;21(11):1806-1813. doi: 10.1016/j.drudis.2016.06.025. Epub 2016 Jun 29.
5
Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants.
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2888-94. doi: 10.1128/AAC.03086-15. Print 2016 May.
6
Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms.
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2150-6. doi: 10.1128/AAC.02592-15. Print 2016 Apr.
7
Therapeutic drug monitoring in neonates.
Arch Dis Child. 2016 Apr;101(4):377-81. doi: 10.1136/archdischild-2013-305309. Epub 2016 Jan 22.
8
Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1013-21. doi: 10.1128/AAC.01968-15. Print 2016 Feb.
9
Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
Antimicrob Agents Chemother. 2015 Oct;59(10):6344-51. doi: 10.1128/AAC.01157-15. Epub 2015 Jul 27.
10
Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.
Infect Dis Ther. 2015 Jun;4(2):187-98. doi: 10.1007/s40121-015-0067-9. Epub 2015 May 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验